Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Czyz Z"" wg kryterium: Autor


Tytuł :
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
Autorzy :
Werner-Klein M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. .
Grujovic A; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Telexos GmbH, Weilheim, Germany.
Irlbeck C; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Obradović M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Wellmera AG, Basel, Switzerland.
Hoffmann M; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Koerkel-Qu H; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Lu X; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Treitschke S; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Köstler C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Botteron C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Weidele K; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Werno C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Polzer B; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Kirsch S; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Gužvić M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Warfsmann J; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Honarnejad K; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Czyz Z; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Feliciello G; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Blochberger I; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Grunewald S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Schneider E; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Haunschild G; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Patwary N; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Guetter S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Huber S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Rack B; Department OB&GYN and CCCLMU, Breast Center, LMU University Hospital, 80337, Munich, Germany.; Department of Gynecology, Ulm University Hospital, Ulm, Germany.
Harbeck N; Department OB&GYN and CCCLMU, Breast Center, LMU University Hospital, 80337, Munich, Germany.
Buchholz S; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, 93053, Regensburg, Germany.
Rümmele P; Department of Pathology, University of Regensburg, 93053, Regensburg, Germany.; Institute of Pathology, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Heine N; University Center of Plastic-, Aesthetic, Hand- and Reconstructive Surgery, University of Regensburg, Regensburg, Germany.
Rose-John S; Institute of Biochemistry, Christian-Albrechts-Universität Kiel, Kiel, Germany.
Klein CA; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. .; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Oct 05; Vol. 11 (1), pp. 4977. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Signal Transduction*
Interleukin-6/*metabolism
Neoplastic Stem Cells/*metabolism
Neoplastic Stem Cells/*pathology
Bone Marrow/pathology ; Breast/cytology ; Breast Neoplasms/pathology ; Class I Phosphatidylinositol 3-Kinases/genetics ; Class I Phosphatidylinositol 3-Kinases/metabolism ; Cytokine Receptor gp130/metabolism ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Female ; Humans ; Interleukin-6/genetics ; Mutation ; Neoplasm Metastasis/genetics ; Receptors, Interleukin-6/deficiency ; Receptors, Interleukin-6/metabolism ; Stromal Cells/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Measurement of the Flow Field Generated by Multicopter Propellers.
Autorzy :
Czyż Z; Aeronautics Faculty, Military University of Aviation, 08-521 Dęblin, Poland.
Karpiński P; Department of Thermodynamics, Fluid Mechanics and Aviation Propulsion Systems, Faculty of Mechanical Engineering, Lublin University of Technology, 20-618 Lublin, Poland.
Stryczniewicz W; Aerodynamics Department, Łukasiewicz Institute of Aviation, 02-256 Warsaw, Poland.
Pokaż więcej
Źródło :
Sensors (Basel, Switzerland) [Sensors (Basel)] 2020 Sep 27; Vol. 20 (19). Date of Electronic Publication: 2020 Sep 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Measurements of Aerodynamic Interference of a Hybrid Aircraft with Multirotor Propulsion.
Autorzy :
Czyż Z; Aeronautics Faculty, Military University of Aviation, 35 Dywizjonu 303 St., 08-521 Dęblin, Poland.
Wendeker M; Department of Thermodynamics, Fluid Mechanics and Aviation Propulsion Systems, Faculty of Mechanical Engineering, Lublin University of Technology, 36 Nadbystrzycka St., 20-618 Lublin, Poland.
Pokaż więcej
Źródło :
Sensors (Basel, Switzerland) [Sensors (Basel)] 2020 Jun 13; Vol. 20 (12). Date of Electronic Publication: 2020 Jun 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma.
Autorzy :
Werner-Klein M; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Scheitler S; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Hoffmann M; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Hodak I; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Dietz K; Department of Medical Biometry, University of Tübingen, Silcherstr. 5, 72076, Tübingen, Germany.
Lehnert P; Department of Dermatology, University of Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany.
Naimer V; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Polzer B; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Treitschke S; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Werno C; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Markiewicz A; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Weidele K; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Czyz Z; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany.
Hohenleutner U; Department of Dermatology, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Hafner C; Department of Dermatology, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Haferkamp S; Department of Dermatology, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Berneburg M; Department of Dermatology, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.
Rümmele P; Department of Pathology, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany.; Institute of Pathology, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany.
Ulmer A; Department of Dermatology, University of Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany.
Klein CA; Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053, Regensburg, Germany. .; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, Am Biopark 9, 93053, Germany. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2018 Feb 09; Vol. 9 (1), pp. 595. Date of Electronic Publication: 2018 Feb 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Melanoma/*genetics
Skin/*metabolism
Skin Neoplasms/*genetics
Animals ; Cell Line, Tumor ; Comparative Genomic Hybridization/methods ; Female ; GTP Phosphohydrolases/genetics ; Humans ; Lymph Nodes/metabolism ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Male ; Melanoma/pathology ; Membrane Proteins/genetics ; Mice, Inbred NOD ; Mice, Knockout ; Mice, SCID ; Proto-Oncogene Proteins p21(ras)/genetics ; Skin/pathology ; Skin Neoplasms/pathology ; Transplantation, Heterologous
Czasopismo naukowe
Tytuł :
HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category.
Autorzy :
Holzschuh MA; Department of Gynaecology and Obstetrics, University Medical Centre Regensburg, Regensburg, Germany.
Czyz Z; Project Group 'Personalized Tumour Therapy', Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.
Hauke S; ZytoVision GmbH, Bremerhaven, Germany.
Inwald EC; Department of Gynaecology and Obstetrics, University Medical Centre Regensburg, Regensburg, Germany.
Polzer B; Project Group 'Personalized Tumour Therapy', Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.
Brockhoff G; Department of Gynaecology and Obstetrics, University Medical Centre Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2017 Oct; Vol. 71 (4), pp. 610-625. Date of Electronic Publication: 2017 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*genetics
Breast Neoplasms/*classification
Chromosomes, Human, Pair 17/*genetics
Receptor, ErbB-2/*genetics
Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Centromere/genetics ; Chromosome Aberrations ; Comparative Genomic Hybridization ; Female ; Gene Dosage ; Humans ; In Situ Hybridization
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies